硫酸软骨素市场 - 增长、趋势、COVID-19 影响和预测(2022 - 2027 年)

硫酸软骨素市场按来源、应用(制药、化妆品和兽医)、地理划分

硫酸软骨素市场快照

Chondroitin Sulfate Market
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: >6 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

骨关节炎的高患病率是硫酸软骨素市场增长的主要驱动因素。美国国立卫生研究院 (NIH) 在其报告中指出,2017 年美国有超过 3000 万成年人被诊断出患有骨关节炎 (OA)。人口老龄化和所有年龄组的肥胖症增加是主要原因骨关节炎在该国。

此外,硫酸软骨素在各种治疗中的应用不断增加,正在推动全球硫酸软骨素的整体市场增长。不仅用于治疗骨关节炎,而且硫酸软骨素也用于滴眼剂中以治疗干眼症。此外,它还用于白内障手术期间移植时保护角膜的溶液。

2015年4月,参天药业推出以硫酸软骨素钠为有效成分的OTC眼药水新桑特德Uα,用于缓解眼部疲劳,预防眼部疾病。

报告范围

根据报告的范围,硫酸软骨素是一种糖胺聚糖,它是许多结缔组织(包括软骨、骨骼、皮肤、韧带和肌腱)的细胞外基质 (ECM) 的主要成分。在补充剂中,硫酸软骨素通常来自动物软骨。

By Source
Swine
Shark
Bovine
Synthetic
Others
By Application
Pharmaceuticals
Cosmetics
Veterinary
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

主要市场趋势

医药板块有望占据重要市场份额

硫酸软骨素主要用于治疗骨关节炎。它通常与硫酸氨基葡萄糖、抗坏血酸锰、N-乙酰氨基葡萄糖或盐酸氨基葡萄糖等其他成分结合使用。硫酸软骨素也可口服用于心脏病发作、艾滋病毒/艾滋病、心脏病、骨质疏松症、关节痛,因为这些药物用于治疗乳腺癌、高胆固醇、运动后肌肉酸痛、胃酸反流、间质性膀胱炎、大骨节疾病和牛皮癣。

硫酸软骨素被 FDA 批准用作治疗干眼症的滴眼液,也可用作白内障手术期间保护角膜的溶液。2017 年,专注于眼科的制药公司 Imprimis Pharmaceuticals Inc. 宣布已就 Klarity、眼科外用溶液和干眼症 (DED) 患者凝胶技术的全球独家权利达成许可协议

硫酸软骨素软膏与硫酸氨基葡萄糖、鲨鱼软骨和樟脑联合可用于治疗骨关节炎的疼痛。有些患者会将硫酸软骨素注射到肌肉中以治疗骨关节炎,有些患者会将硫酸软骨素注射到膀胱中以治疗尿路感染、膀胱状况或膀胱失控。因此,硫酸软骨素的药用应用范围很广,预计各自的细分市场将显着增长。

Chondroitin Sulphate Market

北美在全球硫酸软骨素市场占有主要份额

北美地区成熟的制药行业和美国食品药品监督管理局对硫酸软骨素的批准增加可归功于该地区硫酸软骨素市场的增长。 

骨关节炎的高发病率和白内障手术中胆固醇使用的增加以及眼药水的配方也是促进北美增长的几个因素。2017 年 11 月,Gnosis 向美国市场推出了第一款含有 Mythocondro 的膳食补充剂,这是一种独特的 100% 纯素硫酸软骨素,类似于人体滑液。

由于骨关节炎的高发病率以及对硫酸软骨素在个人护理和营养补充剂中应用的认识不断提高,预计亚太地区将成为预测期内增长最快的地区。

Chondroitin Sulfate Market

竞争格局

由于许多制造商的存在,市场竞争适度。由于对产品创新的研发投资增加以及通过向市场推出新产品来提高产品效率,市场竞争较为温和。随着使用硫酸软骨素的骨关节炎和其他适应症的流行率上升,相信未来很少有中小型公司会进入市场。

主要玩家

  1. FIDIA FARMACEUTICI S.P.A.

  2. GNOSIS S.p.A.

  3. Merck KGaA (Sigma-Aldrich, Inc)

  4. Synutra, Inc.

  5. Summit Nutritionals International

Chondroitin Sulfate Market

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Prevalence of Osteoarthritis

      2. 4.2.2 Growing Applications of Chondroitin Sulfate

    3. 4.3 Market Restraints

      1. 4.3.1 Adverse Effects of Chondroitin Sulfate

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Source

      1. 5.1.1 Swine

      2. 5.1.2 Shark

      3. 5.1.3 Bovine

      4. 5.1.4 Synthetic

      5. 5.1.5 Others

    2. 5.2 By Application

      1. 5.2.1 Pharmaceuticals

      2. 5.2.2 Cosmetics

      3. 5.2.3 Veterinary

    3. 5.3 Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States

        2. 5.3.1.2 Canada

        3. 5.3.1.3 Mexico

      2. 5.3.2 Europe

        1. 5.3.2.1 Germany

        2. 5.3.2.2 United Kingdom

        3. 5.3.2.3 France

        4. 5.3.2.4 Italy

        5. 5.3.2.5 Spain

        6. 5.3.2.6 Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. 5.3.3.1 China

        2. 5.3.3.2 Japan

        3. 5.3.3.3 India

        4. 5.3.3.4 Australia

        5. 5.3.3.5 South Korea

        6. 5.3.3.6 Rest of Asia-Pacific

      4. 5.3.4 Middle-East and Africa

        1. 5.3.4.1 GCC

        2. 5.3.4.2 South Africa

        3. 5.3.4.3 Rest of Middle-East and Africa

      5. 5.3.5 South America

        1. 5.3.5.1 Brazil

        2. 5.3.5.2 Argentina

        3. 5.3.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Bioiberica S.A.U

      2. 6.1.2 FIDIA FARMACEUTICI S.P.A.,

      3. 6.1.3 GNOSIS S.p.A.

      4. 6.1.4 Nutramax Laboratories Inc.

      5. 6.1.5 Santen Pharmaceutical Co., Ltd.

      6. 6.1.6 Merck KGaA (Sigma-Aldrich, Inc)

      7. 6.1.7 Synutra, Inc.

      8. 6.1.8 Summit Nutritionals International

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Chondroitin Sulfate Market market is studied from 2018 - 2026.

The Chondroitin Sulfate Market is growing at a CAGR of >6% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

FIDIA FARMACEUTICI S.P.A., GNOSIS S.p.A., Merck KGaA (Sigma-Aldrich, Inc), Synutra, Inc., Summit Nutritionals International are the major companies operating in Chondroitin Sulfate Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!